3-((4-Methylpiperazin-1-yl)methyl)phenylboronic acid, 97%, 250mg

Aluminum Glycinate>97.0%(T)500g

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1R,2R)-2-(dimethylamino)cyclohexyl]amino]-3-cyclobutene-1,2-dione, 97%, 1g

Methyl 6-amino-4-bromopicolinate, 95.0%, 100mg

1-Methyl-1H-pyrazole-4-carboxylic acid, 97.0%, 5g

2,2,3,3-TETRAMETHYL-4,7,10,13-TETRAOXA-3-SILAPENTADECAN-15-OL, 95.0%, 5g

tert-Butyl (trans-4-acetylcyclohexyl)carbamate, 98%, 10g

4-Chloro-5,6-difluoronicotinic acid, 95.0%, 10g

Oxion Inverso OX.2053-PLPH with LWD Plan phase 10x/20x/40x objectives and XY cross table

2-Chloromethyl-6-trifluoromethyl-1H-benzoimidazole, 95.0%, 250mg

(5-Chloro-2-isopropoxypyridin-3-yl)boronic acid, 95.0%, 1g

3-((4-(2-methoxyphenoxy)phenyl)sulfonamido)benzoic acid, 95.0%, 250mg

4-Amino-N-(thiazol-2-yl)benzenesulfonamide, 95.0%, 1kg